Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging

American Journal of Clinical Nutrition

Volumn 69, Issue 6, 1999, Pages 1162-1169

  Engelson, Ellen S ^a,b   Kotler, Donald P ^a   Tan, YanXiu ^a   Agin, Denise ^a   Wang, Jack ^a   Pierson Jr , Richard N ^a   Heymsfield, Steven B ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Adipose tissue; Antiretroviral agents; Body cell mass; Body composition; Densitometry; Dual energy X ray absorptiometry; DXA; HIV infection; Humans; Magnetic resonance imaging; MRI; Nutrition assessment; Protease inhibitors; Regional fat distribution; Syndrome X; Truncal enlargement; Visceral adiposity syndrome

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; FAT; PROTEINASE INHIBITOR;

ADULT; ARTICLE; BODY COMPOSITION; BODY DISTRIBUTION; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; SUBCUTANEOUS FAT; TRUNK; VIRUS LOAD; VISCERA;

EID: 0032975155     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.6.1162     Document Type: Article

References (41)

1. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985;42:1255-65.
2. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7.
3. Ott M, Lembke B, Fischer H, et al. Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 1993;57:15-9.
4. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992;55:455-60.
5. Mulligan K, Tai VW, Schambelan M. Energy expenditure in human immunodeficiency virus infection. N Engl J Med 1997;336:70-1.
6. Rivera S, Briggs W, Qian D, Sattler FR. Levels of RNA are quantitatively related to prior weight loss in HIV-associated wasting. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:411-8.
7. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987;317:185-91.
8. Shepp DH, Ashraf A. Effect of didanosine on human immunodeficiency virus viremia and antigenemia in patients with advanced disease: correlation with clinical response. J Infect Dis 1993;167:30-5.
9. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8.
10. Miller KD, Jones E, Yanovski JA, Shanker R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998;351:871-5.
11. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet 1998;351:867-70.
12. Chisholm DJ, Campbell LV, Kragen EW. Pathogenesis of the insulin resistance syndrome (syndrome X). Clin Exp Pharmacol Physiol 1997;24:782-4.
13. Bjorntorp P. Abdominal obesity and the development of noninsulin dependent diabetes mellitus. Diabetes Metab Rev 1988;4:615-22.
14. Larsson P, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 1984;288:1401-4.
15. Heymsfield SB, Ross R, Wang Z, Frager D. Imaging technique of body composition. Advantages of measurement and new uses. In: Carlson-Newberry SJ, Costello RB, eds. Imaging technologies for nutrition research. Washington, DC: National Academy Press, 1997:127-50.
16. Ross R, Rissaneu J, Pedwell H, Clifford J, Shragge P. Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men. J Appl Physiol 1996;81:2445-55.
17. Ross R. Magnetic resonance imaging provides new insights into the characterization of adipose and lean tissue distribution. Can J Clin Pharmacol 1996;74:778-85.
18. Gallagher D, Belmonte D, Deurenberg P, et al. Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. Am J Physiol 1998;275:E1-10.
19. Heymsfield SB, Wang J, Funfar J, Kehayias JJ, Pierson RN. Dual-photon absorptiometry: comparison of bone mineral and soft tissue mass measurements in vivo with established methods. Am J Clin Nutr 1989;49:1283-9.
20. Heymsfield SB, Smith R, Aulet M, et al. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 1990;52:214-8.
21. Heymsfield SB, Wang ZM, Baumgartner RN, Ross R. Human body composition: advances in models and methods. Annu Rev Nutr 1997;17:527-58.
22. Pierson RN Jr, Lin DHY, Phillips RA. Total-body potassium in health: effects of age, sex, height, and fat. Am J Physiol 1974;226:206-12.
23. Pierson RN Jr, Wang J, Thornton JC, Van Itallie TB, Colt EWD. Body potassium by four-pi counting: an anthropometric correction. Am J Physiol 1984;246:F234-9.
24. Moore FD, Olesen KH, McMurray JD, Parker HV, Ball MR, Boyden CM. The body cell mass and its supporting environment. Philadelphia: WB Saunders, 1963.
25. Von Roenn JH, Armstrong D, Kotler DP, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994;121:393-9.
26. Tyrrell JB. Glucocorticoid therapy. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and metabolism. 3rd ed. New York: McGraw-Hill, 1995:859.
27. Lancaster JL, Ghiatas AA, Alyassin A, Kilcoyne RF, Bonora E, DeFronzo RA. Measurement of abdominal fat with T1-weighted MR images. J Magn Reson Imaging 1991;1:363-9.
28. Mayo-Smith W, Hayes CW, Biller BMK, Klibanski A, Rosenthal H, Rosenthal DI. Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology 1989;170:515-8.
29. Weaver TW, Kushi LH, McGovern PG, et al. Validation study of self-reported measures of fat distribution. Int J Obes 1996;20:644-50.
30. Ross R, Shaw KD, Rissanen J, Martel Y, de Guise J, Avruch L. Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. Am J Clin Nutr 1994;59:1277-85.
31. Dong K, Bausserman L, Flynn M, et al. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HART). JAMA (in press).
32. Roth VR, Kravcik S, Angel JB. Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors. Clin Infect Dis 1998;27:65-7.
33. Kotler DP, Rosenberg K, Wang J, Pierson RN. Studies of body composition and fat distribution in HIV-infected and control subjects. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:228-37.
34. Flexner C. HIV-protease inhibitors. N Engl J Med 1998;338:1281-92.
35. Miller KK, Daly PA, Sentochnik D, et al. Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients. Clin Infect Dis 1998;27:68-72.
36. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab 1996;20:291-302.
37. Khaw KT, Chir MBB, Barrett-Connor E. Lower endogenous androgens predict central obesity in men. Am J Epidemiol 1992;2:675-82.
38. Snel YEM, Brummer RJM, Doerga ME, et al. Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subject. Am J Clin Nutr 1995;61:1290-4.
39. Rissanen J, Hudson R, Ross R. Visceral adiposity, androgens, and plasma lipids in obese men. Metabolism 1994;43:1318-23.
40. Seidell JC, Bjorntorp P, Sjostrom L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose and C-peptide levels, but negatively with testosterone levels. Metabolism 1990;39:897-901.
41. Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998;351:1328 (letter).